The London Clinic Advanced Therapies Centre
The London Clinic expands clinical research programme
with launch of new Advanced Therapies Centre.
The London Clinic has launched the Advanced Therapies Centre, a
new facility which aims to provide innovative treatment choices for
patients by supporting clinical trials, a Named Patient Programme
(NPP) and enabling access to novel therapies.
The Advanced Therapies Centre, which is part of a broader
Clinical Research programme at The London Clinic, and one of the
first clinical trials programme in the independent healthcare
sector, will focus on Phase II and III clinical trials and medical
device trials, offering patients access to the latest advances in
treatments.
The Advanced Therapies Centre provides a number of benefits to
both consultants and patients. It is housed in The London Clinic’s
new £90 million cancer centre, which can provide the latest
treatment, cutting edge technology and world leading expertise. The
Named Patient Programme allows equal access for private patients to
unlicensed medication and off-label treatment in a controlled
environment. Patients involved in the clinical trials will have
consistent care with 24 hour emergency cover to all consultants and
a pharmacy that can formulate treatment as required.
Further benefits of the central coordination of the Advanced
Therapies Centre include a rapid study set up time in 42 days
R&D approval time, compared to 56-120 days in NHS Trusts, as
well as rapid patient recruitment with access via consultants’
private practices, accurate estimation of numbers, and access to
patients unlikely to have taken part in previous clinical
trials.
The first clinical trials being undertaken at the Advanced
Therapies Centre focus on oncology, haematology and medical
devices, and will include studies of immunotherapy agents in
pancreatic, colorectal and melanoma (and other tumour groups).
Further proposed studies include a comparison of the superiority of
stereotactic radiosurgery with CyberKnife for cancers that have
metastasized. New studies also include a world first
prosthesis/resurfacing knee implant medical device study called
BioPoly.
The Advanced Therapies Centre consists of a multidisciplinary
team of specialist pharmacists, research governance and quality
assurance facilitators, a Macmillan Cancer Information Nurse
Specialist and consultant advisors from the NHS, academia and the
pharmaceutical industry. The Centre further cements The London
Clinic’s commitment to clinical investigation and, as part of a
wider clinical research programme, it also supports the charitable
status by contributing to the scientific foundation of future
clinical treatment and management of patients in the UK.
The Advanced Therapies Centre is run by an experienced and
established trials team at The London Clinic, including Clinical
Trials Manager, Alistair Gifford-Moore.
Contact us
The advanced therapies centre welcomes enquiries from patients,
GPs and consultants about participating in any of the ongoing,
planned or future clinical trials at The London Clinic. For more
information on enrolment in this trial please contact the advanced
therapies centre directly.
atc@thelondonclinic.co.uk
Tel: 0203 219 3570
Mob: 07714 396278
Bleep: Bleep 315